Le Lézard
Classified in: Health, Business
Subjects: ACC, MAT

PURA - Puration Announces $5 Million Investment Term Sheet with $0.10 PPS Valuation


DALLAS, Feb. 4, 2020 /PRNewswire/ -- Puration, Inc. (USOTC: PURA) today announced receiving a $5 million investment term sheet intended to fund the prospective acquisition of cannabis infused beverage, edible and topical operations. PURA recently revealed plans to pursue the prevailing cannabis consolidation market opportunity by acquiring smaller cannabis infusion companies.  Multiple cannabis investment market analysts have forecasted a market wide consolidation as larger cannabis sector firms acquire smaller firms.  The proposed investment terms outline an up to $5 million debt facility whereby funds would be drawn as needed to fund acquisitions.  The drawn funds would be secured by the acquired asset and the debt could be repaid in stock at $0.10 per share.  PURA anticipates making its first formal acquisition offer within the next 10 days and likewise finalizing terms on the term sheet announced today in order to utilize a first draw in conjunction with the first acquisition.

For more information on Puration, visit http://www.purationinc.com

Disclaimer/Safe Harbor: 

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. 

Contact:
Puration, Inc.
Brian Shibley,
[email protected]
(800) 861-1350 

 

 

SOURCE Puration, Inc.


These press releases may also interest you

at 19:28
Allison Transmission announced today that International Truck, a Navistar brand, has integrated Allison fully automatic transmissions into S13-equipped trucks. Through the partnership's continued collaboration, the award-winning Allison 3414 Regional...

at 19:22
SK hynix Inc. (or "the company", www.skhynix.com) announced today that it recorded 12.43 trillion won in revenues, 2.886 trillion won in operating...

at 19:14
On April 11, 2024, Corporación Financiera de Desarrollo S.A. ("COFIDE") announced the commencement of a cash tender offer (the "Offer") for any and all of its outstanding US$255,000,000 aggregate principal amount of 5.250% Fixed-to-Floating Rate...

at 19:10
Royal Helium Ltd. ("Royal" or the "Company") is pleased to announce that it has entered into an agreement with Research Capital Corporation as the lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters (collectively, the...

at 19:00
A B.C. resident has paid $10,000 to the B.C. Securities Commission (BCSC) and agreed to a temporary market ban after admitting to advising on and trading in securities without being registered. Wayne Lo entered into informal investment agreements...

at 19:00
Terra Drone Corporation, a leading drone and Advanced Air Mobility (AAM) technology provider headquartered in Japan, announced today the launch of joint development with its Group companies Unifly NV ("Unifly") and Aloft Technologies Inc. ("Aloft")...



News published on and distributed by: